Comprehensive Analysis of Six Biomarkers Expression in Early-stage Breast Cancer: A Cross-sectional Study
Breast cancer is a heterogeneous disease with variable molecular profiles. This study aims to evaluate the expression of estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, phosphatidylinositol-4,5- bisphosphate 3-kinase catalytic subunit alpha, interleukin-8, and antigen Kiel 67 in early-stage breast cancer and their associations with clinicopathological features.
Read more